etoposide has been researched along with malondialdehyde in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baudin, B; Bénéteau-Burnat, B; Bruneel, A; Grenet, K; Mailloux, A; Vaubourdolle, M | 1 |
| Baudin, B; Deslandes, B; Mailloux, A; Vaubourdolle, M | 1 |
| Baran, J; Bukowska-Straková, K; Krzysciak, W; Papiez, MA | 1 |
| Abid, S; Achour, A; Amara, I; Azzebi, A; Bacha, H; Bousabbeh, M; Guedri, Y; Rjiba-Touati, K; Salem, IB | 1 |
4 other study(ies) available for etoposide and malondialdehyde
| Article | Year |
|---|---|
Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Bleomycin; Cells, Cultured; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Endothelium, Vascular; Etoposide; Glutathione; Humans; Immunohistochemistry; L-Lactate Dehydrogenase; Malondialdehyde; Necrosis; Oxidative Stress; Paclitaxel; Peptidyl-Dipeptidase A; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Umbilical Veins | 2001 |
Captopril and enalaprilat decrease antioxidant defences in human endothelial cells and are unable to protect against apoptosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Apoptosis; Captopril; Cells, Cultured; Dose-Response Relationship, Drug; Enalaprilat; Endothelium, Vascular; Etoposide; Glutathione Peroxidase; Humans; Lipid Peroxidation; Malondialdehyde; Necrosis; Oxidative Stress; Superoxide Dismutase; Umbilical Veins | 2003 |
(-)-Epicatechin enhances etoposide-induced antileukaemic effect in rats with acute myeloid leukaemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Marrow Cells; Catechin; Drug Synergism; Etoposide; Fluorescence Recovery After Photobleaching; Leukemia, Promyelocytic, Acute; Lipid Peroxidation; Male; Malondialdehyde; Organ Size; Rats; Rats, Inbred BN; Spleen; Superoxide Dismutase | 2012 |
Recombinant human erythropoietin prevents etoposide- and methotrexate-induced toxicity in kidney and liver tissues via the regulation of oxidative damage and genotoxicity in Wistar rats.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Catalase; Chemical and Drug Induced Liver Injury; DNA Damage; Erythropoietin; Etoposide; Glutathione; Kidney; Kidney Diseases; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methotrexate; Protective Agents; Rats, Wistar; Recombinant Proteins | 2018 |